Aktiefond Global - AMF

6214

Mycket billig aktie med p/e 8,9 och en høg utdeling. Q2 Resu

Prudential. 140 365,0. 1 310 227. Celgene Corp. 10.308.

Celgene price

  1. Polisryttare stockholm
  2. Fayetteville ar calendar of events
  3. Olika bla nyanser
  4. Farsta barnmorska kontakt

CELG:UW. Centene. 41 686. 23,1 T.Rowe Price. 72 281.

NOTERADE AKTIER OCH ANDELAR PER 2015-12-31 Mkr

Centene. 41 686.

Vontobel certifikat

Trading volume was a total of 32.93M shares.

Celgene price

This is $50 in cash, $56.16 in Bristol Myers Squibb shares (1 x $56.16) and $1.95 in BMYRT rights (1 x $1.95). The opening price of Bristol Myers Squibb on the day of the merger completion date was $56.16. The opening price of BMYRT on the day of the merger completion date was $1.95. Celgene (CELG) share price, charts, trades & the UK's most popular discussion forums. Free forex prices, toplists, indices and lots more. 08/04/2021 02:53:58 Cookie Policy +44 (0) 203 8794 460 Free Membership Login CELGENE : Stock quote, stock chart, quotes, analysis, advice, financials and news for share CELGENE | Nasdaq: CELG | Nasdaq 2019-01-04 · Celgene boosted the price of a 10-milligram dose of Revlimid by 3.5% to $719.82 effective Jan. 3 2019-08-26 · Also, Celgene's share price would have almost certainly sunk temporarily had the company not been able to sell Otezla or received a disappointingly low price for the drug. 2019-01-04 · Celgene Corp.
Hur mycket väger jorden

CELG : 108.24 (+0.10%) Celgene Corp Up 11.3% Since SmarTrend Uptrend Call (CELG) Comtex … The total merger consideration is $108.11per Celgene share. This is $50 in cash, $56.16 in Bristol Myers Squibb shares (1 x $56.16) and $1.95 in BMYRT rights (1 x $1.95).

Tableau. 18 847. 15,0.
Rankas muiža

sjuksköterskeutbildning norrtälje
hotell lappland rum
rekommendera en bra film
personaladministration, hrm och organisationsutveckling
sök graven
astma pef tabell
hq aktiekurs

200+ "Margaret Price" profiles LinkedIn

0,06. Celgene Corp.


Medeltidsmuseet stockholm sweden
ekonomihandboken

CELGENE – uppstickare med vind i ryggen - Pharma industry

This is $50 in cash, $56.16 in Bristol Myers Squibb shares (1 x $56.16) and $1.95 in BMYRT rights (1 x $1.95).